Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • LCCC 1317

    Genotype-Directed Phase II Study Of Higher Dose Of Irinotecan In First-Line Metastatic Colorectal Cancer Patients Treated With FOLFIRI Plus Bevacizumab

  • NSABP MPR-1

    Patient Registry and Biospecimens Profiling Repository

  • SWOG S1406

    Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer.

Showing trials 1-3 of 3

Also in this Section